Related Experiment Video
Updated: Aug 22, 2026
Quantitative 3D In Silico Modeling (q3DISM) of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
Published on: December 26, 2016
Microglia kill amyloid-beta1-42 damaged neurons by a CD14-dependent process
Clive Bate1, Robert Veerhuis, Piet Eikelenboom
1Institute of Comparative Medicine, Department of Veterinary Pathology, Glasgow University Veterinary School, Bearsden Road, Glasgow G61 1QH, UK. c.bate@vet.gla.ac.uk
Abstract:
Activated microglia are closely associated with neuronal damage in Alzheimer's disease. In the present study, neurons exposed to low concentrations of amyloid-beta1-42, a toxic fragment of the amyloid-beta protein, were killed by microglia in a process that required cell-cell contact. Pre-treating microglia with polyclonal antibodies to the CD14 protein, or treating neurons exposed to amyloid-beta1-42 with a CD14-IgG chimera, prevented the killing of amyloid-beta1-42 damaged neurons by microglia. Moreover, microglia from CD14 null mice failed to kill amyloid-beta1-42 damaged neurons. Increased neuronal survival was accompanied by a significant reduction in the production of interleukin-6 indicative of reduced microglial activation. These results indicate an important role for CD14 in the recognition and subsequent killing of amyloid-beta damaged neurons by microglia.
Insights
Activated microglia contribute to neuronal damage in Alzheimer's disease. This study shows CD14 protein is crucial for microglia recognizing and killing amyloid-beta damaged neurons, offering a potential therapeutic target.
Area of Science:
- Neuroscience
- Immunology
Background:
- Activated microglia are implicated in neuronal damage observed in Alzheimer's disease.
- Amyloid-beta (Aβ) protein fragments, particularly Aβ1-42, are toxic to neurons.
Purpose of the Study:
- To investigate the role of the CD14 protein in microglial-mediated killing of amyloid-beta damaged neurons.
- To understand the mechanism by which microglia recognize and eliminate damaged neurons in the context of Alzheimer's disease pathology.
Main Methods:
- Utilized in vitro models with neurons exposed to amyloid-beta1-42.
- Employed microglia, including those from CD14 null mice.
- Investigated the effects of CD14 antibodies and CD14-IgG chimeras on microglial-neuron interactions.
- Measured neuronal survival and interleukin-6 production as indicators of microglial activation.
Main Results:
- Microglia killed amyloid-beta1-42 damaged neurons through cell-cell contact.
- Blocking CD14 on microglia or using a CD14-IgG chimera on neurons prevented microglial killing.
- Microglia from CD14 null mice did not kill amyloid-beta damaged neurons.
- Reduced interleukin-6 production indicated decreased microglial activation with CD14 intervention.
Conclusions:
- CD14 plays a critical role in the recognition of amyloid-beta damaged neurons by microglia.
- CD14 mediates the microglial-dependent killing of neurons exposed to amyloid-beta.
- Targeting CD14 may represent a therapeutic strategy to protect neurons in Alzheimer's disease.
